PharmacoEconomics & Outcomes News

, Volume 769, Issue 1, pp 3–3 | Cite as

Apixaban most cost effective for stroke prevention in AF

Clinical study
  • 16 Downloads

Reference

  1. Liu CY, et al. Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan. Clinical Drug Investigation : 17 Dec 2016. Available from: URL: http://doi.org/10.1007/s40261-016-0487-7

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations